Under the 340B program, eligible hospitals buy drugs at a discounted price in order to offset the cost of treating low income ...

HRSA is piloting a 340B rebate model similar to one that it just fought against. As the agency dips its toes into the 340B debate, hospital groups express concerns about the potential for cash flow ...

On the heels of multiple lawsuits disrupting drug manufacturers’ efforts to convert the 340B Program into a rebate-based model, the Health Resources and Services Administration (HRSA) released a ...

The 340B rebate pilot model set to begin in January 2026 starkly presents the key tradeoff between program integrity and ...

The 340B Drug Pricing Program (“340B Program”) space continues to be a hive of activity. While 340B stakeholders continue to litigate ongoing manufacturer contract pharmacy restrictions, states ...

The 340B Drug Pricing Program was designed to help safety net providers serve low-income patients, but it has since ballooned into a multibillion-dollar system dominated by large health systems — with ...

The Trump administration has approved eight drugmakers' rebate plans for a controversial 340B drug discount pilot program that kicks off Jan. 1. The 340B Rebate Model Pilot Program, unveiled this ...

Ryan Long, the co-author of a recent USC Schaeffer Center white paper on the 340B Drug Pricing Program, argues that meaningful reform requires shifting to a direct subsidy model based on need. The ...

Jeff Davis, a partner in the Washington, D.C., law office of Bass, Berry & Sims, advises healthcare organizations on Medicare and Medicaid billing and reimbursement issues, with a special focus on the ...

The number of 340B providers has grown from about 10,000 to 66,000 in the past 15 years, while the number of contract pharmacies increased from 1,300 to 253,000 over the same time. The dramatic growth ...

In his recent commentary, "Bill would make flawed drug discount program worse" (May 19), Dr. Luis Rodriguez misrepresents the intent and impact of the 340B Drug Pricing Program. For more than 30 years ...

The dramatic growth of a key federal drug discount program has fueled debate about whether it is helping low-income patients as intended or primarily benefiting health care providers. Subscribe to our ...